STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Biotechnology

KindlyMD and Nakamoto Merge to Launch Largest Bitcoin Treasury Initiative in Public Markets

byLuca Blaumann
May 12, 2025
in Biotechnology, Bitcoin, Small-Cap
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

$710 Million Raised as David Bailey Leads Ambitious Plan to Transform Bitcoin Adoption Through Public Equity

In a landmark move bridging healthcare innovation and digital finance, KindlyMD (KDLY) has announced a definitive merger agreement with Nakamoto Holdings Inc., a Bitcoin-native holding company founded by Bitcoin advocate David Bailey. The transaction aims to establish the largest publicly traded Bitcoin treasury platform, backed by a massive $710 million in funding.

The deal includes a $510 million fully committed PIPE (private investment in public equity) and $200 million in senior secured convertible notes, marking the largest capital raise to date for a public crypto-related transaction. With Bailey stepping in as CEO of the combined entity, the partnership signals a bold strategy to bring Bitcoin further into the mainstream capital markets.

Nakamoto Holdings, in collaboration with BTC Inc—the publisher of Bitcoin Magazine and organizer of the annual Bitcoin Conference—plans to create a global network of Bitcoin treasury companies. Its goal: to package Bitcoin into investor-friendly instruments such as equity, debt, and hybrid securities, and list them on major exchanges worldwide.

“Traditional finance and Bitcoin-native markets are converging,” said Bailey. “We believe a future is coming where every balance sheet—public or private—holds Bitcoin. Nakamoto seeks to be the first publicly traded conglomerate designed to accelerate that.”

The merger offers investors exposure to Bitcoin within a transparent, regulatory-compliant public market vehicle. It also brings together an all-star lineup of institutional investors and industry leaders, including ParaFi, VanEck, Arrington Capital, and individual Bitcoin pioneers like Adam Back, Balaji Srinivasan, and Jihan Wu.

Tim Pickett, CEO of KindlyMD, will continue leading the company’s healthcare operations, which will remain focused on combating the opioid crisis through holistic health services. The merger allows KindlyMD to expand its mission while benefiting from Nakamoto’s crypto expertise and access to global Bitcoin resources.

Following the merger, shares will continue to trade on Nasdaq under the symbol “KDLY,” with a planned ticker and name change. The combined company will also assume Nakamoto’s marketing agreement with BTC Inc., helping amplify its Bitcoin treasury strategy through one of the largest media platforms in the digital asset space.

With six board seats designated to Nakamoto and one to KindlyMD, the merger underscores the strategic pivot toward Bitcoin-centered financial operations while maintaining a strong foundation in healthcare services.

Pending shareholder approval and standard regulatory conditions, the merger is expected to close alongside the PIPE and debt financings. This union not only redefines Bitcoin’s role in public markets but may also usher in a new era of institutional crypto adoption on a global scale.

You might like this article:Mira Pharmaceuticals Approves Acquisition of SKNY, Creating $60M+ Biotech Platform

Tags: bitcoinbtcGrowthMoversNewsStock Market
Previous Post

Mira Pharmaceuticals Approves Acquisition of SKNY, Creating $60M+ Biotech Platform

Next Post

Institutional Interest In Telomir Pharmaceuticals

Related Posts

trading-chart

IBM, AMD, Novo Nordisk Lead Midday Market Movers

byLuca Blaumann
February 24, 2026
0

Tech, retail, and healthcare stocks drive volatility as investors react to earnings and AI trends Several major stocks posted notable...

Vanda Pharmaceuticals Gains on FDA Approval of BYSANTI

byLiliana Vida
February 23, 2026
0

Regulatory green light strengthens commercial outlook and expands product portfolio Shares of Vanda Pharmaceuticals (VNDA) moved higher after the company...

Gilead Sciences to Acquire Arcellx, Sending Shares Higher

byLuca Blaumann
February 23, 2026
0

Biotech deal signals strategic expansion in next-generation cell therapies Shares of Arcellx (ACLX) moved higher following the announcement that the...

Next Post

Institutional Interest In Telomir Pharmaceuticals

Latest News

Lucid Reports Mixed Q4 Results as Gravity SUV Ramp Pressures Margins

IBM, AMD, Novo Nordisk Lead Midday Market Movers

Meta and AMD Forge Multiyear AI Chip Partnership

PayPal Draws Takeover Interest After Sharp Stock Decline

Vanda Pharmaceuticals Gains on FDA Approval of BYSANTI

Based on Your Interest

Biotechnology

Gilead Sciences to Acquire Arcellx, Sending Shares Higher

February 23, 2026
Bitcoin

Bitcoin Falls Below $65,000 as Investors Flee Risk Assets

February 23, 2026
investing
Artificial Intelligence

Rackspace Rallies After Strategic AI Partnership with Palantir

February 20, 2026

Recommended

Artificial Intelligence

AMD Backs Crusoe with $300 Million Loan Guarantee to Expand AI Infrastructure

February 19, 2026
Beverages

Amazon Surpasses Walmart as World’s Largest Company by Revenue

February 19, 2026
Ground Transportation

Uber Invests Over $100 Million to Build EV Charging Network for Drivers and Robotaxis

February 18, 2026
Biotechnology

Moderna’s Flu Vaccine Back Under FDA Review After Key Modifications

February 18, 2026
Small-Cap

KULR Technology Partners with Hylio to Develop NDAA-Compliant Drone Battery Systems

February 18, 2026
Stoxpo

Follow us on social media:

Highlights

  • Lucid Reports Mixed Q4 Results as Gravity SUV Ramp Pressures Margins
  • IBM, AMD, Novo Nordisk Lead Midday Market Movers
  • Meta and AMD Forge Multiyear AI Chip Partnership
  • PayPal Draws Takeover Interest After Sharp Stock Decline
  • Vanda Pharmaceuticals Gains on FDA Approval of BYSANTI

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Lucid Reports Mixed Q4 Results as Gravity SUV Ramp Pressures Margins

February 24, 2026
trading-chart

IBM, AMD, Novo Nordisk Lead Midday Market Movers

February 24, 2026
semiconductor-2

Meta and AMD Forge Multiyear AI Chip Partnership

February 24, 2026
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.